Mylan N.V.:企業の戦略・SWOT・財務分析

◆英語タイトル:Mylan N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4658
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mylan N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Mylan N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mylan N.V. (Mylan or ‘the company’) is a pharmaceutical products company that develops and sells branded, generic and over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories. The company sells the products to wholesalers and distributors, retail pharmacy chains, drug store chains, group purchasing organizations, drug manufacturers, independent pharmacies and governmental organizations and markets these products across North America, Europe and other regions worldwide. The company is headquartered in Hatfield, Hertfordshire, the UK.

Scope

- Detailed information on Mylan N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mylan N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Mylan N.V. including a breakdown and examination of key business segments
- Intelligence on Mylan N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mylan N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mylan N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mylan N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mylan N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Mylan N.V.: Company Overview
Mylan N.V.: Overview and Key Facts
Mylan N.V.: Overview
Mylan N.V.: Key Facts
Mylan N.V.: Key Employees
Mylan N.V.: Key Employee Biographies
Mylan N.V.: Major Products and Services
Mylan N.V.: Company History
Mylan N.V.: Management Statement
Mylan N.V.: Locations and Subsidiaries
Mylan N.V.: Key Competitors
Mylan N.V.: Company Analysis
Mylan N.V.: Business Description
Mylan N.V.: SWOT Analysis
Mylan N.V.: SWOT Overview
Mylan N.V.: Strengths
Mylan N.V.: Weaknesses
Mylan N.V.: Opportunities
Mylan N.V.: Threats
Mylan N.V.: Corporate Financial Deals Activity
Mylan N.V.: Financial Deals Overview
Mylan N.V.: Targets and Partners
Mylan N.V.: Top Deals 2016 – 2020YTD*
Mylan N.V.: Advisors
Mylan N.V.: Top Legal Advisors
Mylan N.V.: Top Financial Advisors
Mylan N.V.: Mergers and Acquisitions
Mylan N.V.: Capital Raising
Mylan N.V.: Partnership
Mylan N.V.: Divestments
Mylan N.V.: Recent Developments
Mylan N.V.: News and Events Summary
Mylan N.V.: Business Expansion
Mylan N.V.: Corporate Governance
Mylan N.V.: Corporate Social Responsibility
Mylan N.V.: Financial Performance
Mylan N.V.: Market Developments
Mylan N.V.: Red Flags/DistressSignals
Mylan N.V.: Regulatory and Legal Events
Mylan N.V.: Research & Development
Mylan N.V.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Mylan N.V.: Key Facts
Table 2: Mylan N.V.: Key Employees
Table 3: Mylan N.V.: Company History
Table 4: Mylan N.V.: Locations and Subsidiaries
Table 5: Mylan N.V.: Key Competitors
Table 6: Mylan N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Mylan N.V.: M&A Activity by Geography (TTM*)
Table 8: Mylan N.V.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Mylan N.V.: M&A Average Deal Size - Value (US$m)
Table 10: Mylan N.V.: Targets and Partners
Table 11: Mylan N.V.: Top Deals 2016 - 2020YTD*
Table 12: Mylan N.V.: Legal Advisor Ranking by Value (US$m)
Table 13: Mylan N.V.: Financial Advisor Ranking by Value (US$m)
Table 14: Mylan N.V.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Mylan N.V.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Mylan N.V.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Mylan N.V.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Mylan N.V.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Mylan N.V.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Mylan N.V.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Mylan N.V.: News and Events Summary
Table 22: Mylan N.V.: Business Expansion
Table 23: Mylan N.V.: Corporate Governance
Table 24: Mylan N.V.: Corporate Social Responsibility
Table 25: Mylan N.V.: Financial Performance
Table 26: Mylan N.V.: Market Developments
Table 27: Mylan N.V.: Red Flags/DistressSignals
Table 28: Mylan N.V.: Regulatory and Legal Events
Table 29: Mylan N.V.: Research & Development
Table 30: Mylan N.V.: Strategy and Operations

★海外企業調査レポート[Mylan N.V.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Accord Financial Corp. (ACD):企業の財務・戦略的SWOT分析
    Accord Financial Corp. (ACD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Agilysys Inc (AGYS):企業の財務・戦略的SWOT分析
    Agilysys Inc (AGYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kikkoman Corp:企業の戦略・SWOT・財務分析
    Kikkoman Corp - Strategy, SWOT and Corporate Finance Report Summary Kikkoman Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Khatam al-Anbia:企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SOM Biotech SL:製薬・医療:M&Aディール及び事業提携情報
    Summary SOM Biotech SL (SOM Biotech) is a drug repurposing company that discovers and develops new drugs for orphan indications. The company’s pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duc …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Ryman Healthcare Ltd (RYM):企業の財務・戦略的SWOT分析
    Ryman Healthcare Ltd (RYM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Histogenics Corp (HSGX):医療機器:M&Aディール及び事業提携情報
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • Altius Minerals Corp:企業の戦略・SWOT・財務分析
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Barclays Plc:企業の戦略・SWOT・財務情報
    Barclays Plc - Strategy, SWOT and Corporate Finance Report Summary Barclays Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ALTANA AG:戦略・SWOT・企業財務分析
    ALTANA AG - Strategy, SWOT and Corporate Finance Report Summary ALTANA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Option Care Enterprises Inc:企業の戦略的SWOT分析
    Option Care Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆